Abstract: A device adapted to be installed on a walker is provided where two of the original adjustable feet are removed from the walker and the device is affixed to the remaining vertical tube portions. The device is affixed to the walker in a similar fashion to the adjustable feet. The device has a platform that moves between a stored position and a use position, the stored position is defined by the platform being up and located between the remaining vertical tube portions and the use position is defined by the step being down, allowing the user to sit or stand on the step. When the platform is up, it allows full access to the space around the walker. A leg is connected to the step where the leg hinges down to support the step.

Abstract: A patient support includes a patient support surface, a DVT pump mounted in the patient support, and a port mounted at the patient support in selective fluid communication with the DVT pump. Optionally, the patient support further includes a control system to detect when a DVT device is coupled or in close proximity to the port and/or the type of DVT device. Further, the control system may be configured to control the pump based on the type of DVT device coupled to the port.

Abstract: A foam roller includes a cylindrical body having a passage defined axially therethrough. A support coat made of multiple foam portions includes more than two different colors, and the foam portions are connected to each other by way of heat-pressing. The foam portions are coated to the outer surface of the body and have a first face and a second face. At least the second face has multiple continuous grooves and multiple continuous protrusions, wherein the outer face of each of the protrusions is removed by way of cutting or grinding so as to form a processed face. The processed face and the grooves located on two sides of the processed face have three different colors.

Abstract: A foam roller includes a body having a passage defined axially therethrough. A support coat is connected to the outer surface of the body and has a first layer and a second layer. The first layer has multiple slots through which multiple protrusions formed on the outside of the second layer extend. The protrusions extending through the slots form multiple massage portions. The second layer is connected to the outside of the first layer by way of heat pressing to form the support coat. The first and second layers have different colors. The color of the outside of each massage portion is different from the color of the first layer.

Abstract: A female sexual wellness device configured to provide stimulation frequencies targeting a specific nerve response of clitoral tissue. In one embodiment, the device can alternatively include a motor that creates an oscillatory air pressure wave.

Abstract: A Handheld Motorized Facial Brush Having Specialized Torque Transfer Clip. The heads interface with a conventional handpiece so that the facial brush or other facial treatment head can be removed and replaced with a head chosen from a group of treatment heads. The handpiece has a sealed, washable head portion that can be activated to rotate. Each treatment head or treatment assembly includes a torque transfer clip that provides biasing force between the handpiece and the head, but at the same time results in additional vibration being transferred from the vibration generator in the handpiece to the treatment head. The torque transfer clip also allows for some flex between the treatment head and the handpiece.

Abstract: An example of a resuscitation system is that includes at least two defibrillation electrodes configured to be applied to the exterior of the chest of a patient for delivering a defibrillation shock, a source of one or more ECG signals from the patient, a defibrillation circuit for delivering a defibrillation shock to the defibrillation electrodes, a control box that receives and processes the ECG signals to determine whether a defibrillation shock should be delivered or whether CPR should be performed, and that issues instructions to the user either to deliver a defibrillation shock or to perform CPR, wherein the determination of whether CPR should be performed and the instructions to perform CPR can occur at substantially any point during a rescue.

Abstract: Devices and methods for performing CPR on a patient within an imaging field of an imaging device. The device has a compression belt and a belt tensioning mechanism, both located on or in the device such that the head, neck, thorax and abdomen of the patient may be place within the imaging field with the compression belt installed about the patient and the belt tensioning mechanism will be located outside of the imaging field.

Abstract: A spa control system where the spa's heater is disconnected from the power source anytime the water in the heater is at a higher temperature than that set by the user by a prescribed amount. Since the control system has a regular temperature management'system this will only occur because of a problem in the spa or the control system itself. Independent paths between a pair of temperature sensors in the heater and the relays that connect line voltage to the heater are provided to meet the safety requirements of UL. Two sensors in the heater are co-located in a metal tube, placed near the heater.

Abstract: A footbath has a base member defining a platform. A flexible continuous side wall extends from a proximal end region connected about a periphery of the base member to a distal end region. The side wall has a collapsed position and an extended position. The platform of the base member and the side wall cooperate to define a bath chamber for retaining water with the bath chamber sized to receive a body part. A retention member is supported by the base member to extend from the base member to the distal end region of the side wall to retain the side wall in the extended position.

Abstract: The present invention provides a fluid injection system (11) which transitions between a maintenance mode wherein an outlet (15) is closed and no fluid is discharged through the outlet, and an operation mode, wherein the outlet is open and fluid is discharged through the outlet. The fluid injection system injects a first fluid transported in a first pipeline (21) with a second fluid, wherein there is a temperature differential between the first fluid and the second fluid. The fluid injection system comprises a holding tank (49) for storing the second fluid, a cooling means (35) to cool the second fluid, and a pump (39) for delivering the second fluid into the first pipeline.

Abstract: An exemplary method treating a cardiovascular disease in a patient includes 1) generating, by an electroacupuncture device implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05, and 2) applying, by the electroacupuncture device in accordance with the duty cycle, the stimulation sessions to a median nerve of the patient by way of an electrode array located within the patient at an acupoint corresponding to the median nerve.

Abstract: An overlay is provided for a medication card of the type having a plurality of pharmaceutical products arranged in at least one row. The overlay includes a planar body having a front surface, and a plurality of openings formed in the planar body, with locations of the plurality of openings substantially corresponding to locations of the plurality of products of the medication card. The overlay further includes instructions provided on the front surface of the body for ingesting the plurality of products of the medication card.

Abstract: A blood storage container for the anaerobic storage of blood, having enhanced sealing methods and materials for the preservation of stored blood is provided.

Abstract: Connector assembly including a piercing member having a flow port therein attached to a first piece, with the piercing member slidingly receivable within a second piece, wherein the piercing member and the second pierce are movable relative to each other between a first position where the second pieces closes the flow port and a second position where the flow port is open. The first piece contains a locking mechanism that lockingly engages with a device when connected thereto, preventing subsequent disconnection of first piece and the device. Upon initial connection of the first piece to the device, the second piece is moved from the first position to the second position.

Abstract: An exemplary vial adapter may include a moveable member, an elongated member with a first passage, a second passage coupled to an expandable first reservoir, and a third passage coupled to an expandable second reservoir. In a first orientation of an exemplary vial adapter, a fluid may be directed through the first passage into the first reservoir or the second reservoir. In a second orientation of an exemplary vial adapter, a fluid may be drawn through the first passage and a fluid drawn through an air passage into the second passage. In a second orientation of an exemplary vial adapter, a fluid may be directed through the first passage and through the third passage into the second reservoir. In a first orientation of an exemplary vial adapter, a moveable member may be activated to direct a fluid from the second reservoir through the third passage.

Abstract: A metering device that improves the aseptic transfer of powder and reconstitution fluid into the metering device for medical use. In some implementations, the metering device comprises a housing, containing a metering chamber that defines a volume. The housing also has a connection portion, an extraction portion, and a metering member in fluid communication with the metering chamber. In other embodiments, the metering device additionally includes a dispensing aid that facilitates the dispensing of powder from a first container into the metering chamber through the connection portion. The connection portion is capable of insertion into a second container that contains fluid, thereby allowing a mixture of powder and fluid to form in the metering chamber. The mixture, then ready for use, is removable from the metering chamber through the extraction portion by an extraction device.

Abstract: In certain embodiments, a vial adaptor for removing liquid contents from a vial comprises a piercing member and a bag. The bag can be contained within the piercing member such that the bag is introduced to the vial when the vial adaptor is coupled with the vial. In some embodiments, the bag expands within the vial as liquid is removed from the vial via the adaptor, thereby regulating pressure within the vial. In other embodiments, a vial comprises a bag for regulating pressure within the vial as liquid is removed therefrom. In some embodiments, a vial adaptor is coupled with the vial in order to remove the liquid. In some embodiments, as the liquid is removed from the vial via the adaptor, the bag expands within the vial, and in other embodiments, the bag contracts within the vial.

Abstract: In certain embodiments, a vial adaptor for removing liquid contents from a vial comprises a piercing member and a bag. The bag can be contained within the piercing member such that the bag is introduced to the vial when the vial adaptor is coupled with the vial. In some embodiments, the bag expands within the vial as liquid is removed from the vial via the adaptor, thereby regulating pressure within the vial. In other embodiments, a vial comprises a bag for regulating pressure within the vial as liquid is removed therefrom. In some embodiments, a vial adaptor is coupled with the vial in order to remove the liquid. In some embodiments, as the liquid is removed from the vial via the adaptor, the bag expands within the vial, and in other embodiments, the bag contracts within the vial.

Abstract: A machine for preparing substances for intravenous application includes: an initial container reception zone, a final container reception zone and a substance transfer circuit which includes a set of substance extraction devices, each of which is connected to a flexible tube connected to a device for introducing a substance into the final container by means of a peristaltic pump. The initial container reception zone and the vector of extraction devices are capable of relative movement along a horizontal axis and/or the final container reception zone and the vector of introduction devices are capable of relative movement along a horizontal axis.

Abstract: An exemplary pharmaceutical compounding system and device for mixing materials from at least two distinct material sources can include a transfer set and junction structure that has a junction body, a first inlet port located at a first portion of the junction body, a second inlet port located at a second portion of the junction body, and an outlet port located at a third portion of the junction body. The junction structure can be configured to mix fluid received from both the first inlet port and second inlet port and to deliver the fluid to the outlet port. The junction structure can also include attachment structure located on the junction body and configured to attach the junction structure to the housing of the compounding device at a location downstream of a pump system.

Abstract: The current disclosure is directed to a container with a dispensing schedule and, in various described implementations, to a container and a complementary cap that includes a dispensing schedule. During each dispensing cycle, which includes removing the cap from the container to allow access to the contents of the container and re-securing the cap to the container, the display schedule is automatically advanced to a next indication. In one implementation, the container is a bottle with a threaded neck and the cap is complementarily threaded and has a cylindrical rim and a schedule display. An indication on or within the schedule display is displayed through an aperture in the cap rim. Features included in the cap and the schedule display interoperate to ensure that the displayed indication is advanced to a next indication when the cap is unscrewed from, and subsequently threaded onto, the bottle.

Abstract: A baby feeding kit operational in syringe mode, storage mode, feed-bottle mode, and feed-tube mode. The kit includes a container body, a plunger, an attachable nipple, an attachable cap and a feeding tube. The container body includes a tube portion defining a cavity for holding a liquid having therein, a wide opening disposed at one end and a narrow opening disposed at an opposite end. The plunger removably and sealingly fits inside the cavity and slidably move there along when the container is in a syringe mode, and seals the tube portion when the container is in a storage mode. The attachable nipple sealingly attaches to the wide opening for releasing a liquid held in the container body when sucked on when the container is in a feed-bottle mode in which the plunger is removed, and for pressurizing fluids when the container is in a feed-tube mode, and is removed when the container is in a syringe or storage mode.

Abstract: Disclosed is an NGT system, the system comprises a nasogastric tube having a diameter and length configured to pass through an esophagus such that the lumen of the NGT maintains fluid communication with a portion of the digestive tract, and a digestive tract sensor operatively associated with the NGT, the digestive tract sensor configured to sense from inside the body and transmit signals in response to one or both of conditions relating to nourishment states of the digestive tract, and positioning of the NGT.

Abstract: Dental etchant compositions, processes for making the same, and methods for using the dental etchant compositions are disclosed. The dental etchant compositions include at least one acid and one or more dentin collagen cross-linking agents. The methods for using the dental etchant compositions may include contacting a mammal's tooth with a dental etchant composition that includes one or more acids and one or more dentin collagen cross-linking agents.

Abstract: The present invention provides protein-repellent dental materials that can be widely applied in a variety of dental applications. The protein-repellent dental materials of the invention include dental primers, dental adhesives, dental resins, dental composites, dental bonding systems and the like, as well as dental cements, dental sealants, dental bases and dental liners, each of which is protein-repellent and each of which comprises a protein-repellent agent. In certain aspects, the protein-repellent agent is 2-methacryloyloxyethyl phosphorylcholine (MPC).

Abstract: An array of at least two commonly-branded absorbent articles, such as wipes products. The array includes a first wipes product and a second wipes product. Each wipes product may appeal to a different type of consumer, such as a light experience seeking consumer and a heavy experience seeking consumer. The first wipes product may include a first supply of wipes formed from a first substrate. The first supply of wipes is moistened with a first functional lotion composition including a first fragrance accord and a first lotion formula. The second wipes product may include a second supply of wipes formed from a second substrate. The second supply of wipes is moistened with a second functional lotion composition including a second fragrance accord and a second lotion formula. The second fragrance accord is different from the first fragrance accord, and the second lotion formula is different from the first lotion formula.

Abstract: A particle for the absorption of odiferous compounds, wherein the particle comprises: (a) a solid core comprising a first hydrophobic polymer, and (b) a shell comprising a second hydrophobic polymer wherein the Tg of the first hydrophobic polymer is lower than the Tg of the second hydrophobic polymer; wherein the particles have a mean particle size of less than micron, preferably from 0.1 to 0.3 microns, wherein the odiferous compound is a malodour compound and wherein the ratio of (a):(b) is greater than 2:1.

Abstract: The present invention relates to an anhydrous composition comprising: 1) at least particles releasing a beneficial agent comprising a core containing at least one beneficial agent and an envelope surrounding the core; said envelope comprising at least one hydrophobically modified polysaccharide and at least one water-soluble carbohydrate and/or water-soluble polyol; said particles simultaneously having a poured powder density ranging from 300.0 g/l to 600.0 g/l and an absolute density of greater than 1.0 and 2) at least propellant. The invention also relates to a cosmetic process for caring for and/or for the hygiene of and/or for conditioning and/or for fragrancing and/or for making up a keratin material, which consists in applying to said keratin material a composition as defined previously.

Abstract: The invention relates to a support consisting of natural and/or synthetic fibres which particles are held, which are preferably water-soluble, comprising at least one active agent, said particles at least partially releasing the active agent(s) under the effect of an external stress, characterised in the active agent has a water-solubility of between 0.1 and 60 wt. %, preferably between 0.1 and 30 wt. %.

Abstract: Methods for preparing an eye serum formulation are disclosed. The methods include electrolyzing a saline solution having a salt concentration between about 0.01% and about 1.0% by weight using a voltage between about 0 V and about 30 V across an inert anode and a spaced apart inert cathode to generate a target mixture of chemically reduced and oxidized molecules within the saline solution, mirroring the target mixture of chemically reduced and oxidized species in the electrolyzed saline solution to the reduced species and reactive oxygen species found in a known biological system, adding a rheology modifier, adding a buffering agent, and adding a silicone oil. The target mixture of chemically reduced and oxidized molecules comprises one or more of hypochlorous acid, hypochlorites, dissolved oxygen, chlorine, hydrogen gas, hydrogen peroxide, hydrogen ions, hypochloride, superoxides, ozone, activated hydrogen ions, chloride ions, hydroxides, singlet oxygen, *OCl, and *HO—.

Abstract: The purpose of the present invention is to provide an oil-in-water emulsion composition exhibiting high UV-protective capabilities with which it is possible to uniformly and stably disperse a hydrophobized metal oxide into an inner phase (oil phase) without detracting from the inherent fresh sensation on use of an oil-in-water emulsion composition even when a high amount of the hydrophobized metal oxide is compounded therewith. In summary, the present invention is an oil-in-water emulsion composition characterized by including (A) 0.1-5 mass % of polyether-modified silicone having an HLB (Si) of 5-14, (B) one or more hydrophilic thickeners, (C) a metal oxide hydrophobized by an agent other than metal soap, and (D) nonvolatile oil other than silicone oil, the (C) hydrophobized metal oxide being present in the inner phase.

Abstract: An object of the present disclosure is to investigate fluorescent substance being safe and having a high color developing property, and obtain an inorganic red fluorescent substance consisting of an element which exerts no bad influence upon human bodies. A cosmetic containing inorganic particles consisting of a compound represented by a general formula: MgxTiyO(x+2y+2z):Mn4+z wherein 1.5<x<2.5, 0.5<y?1.5, and 0.0001<z<0.1.

Abstract: Disclosed is a hair conditioning composition comprising: (a) a cationic surfactant; (b) a high melting point fatty compound having a melting point of 25° C. or higher; (c) a monoalkyl glyceryl ether; and (d) an aqueous carrier. The compositions of the present invention provide styling and/or volume benefits together with conditioning benefits.

Abstract: Antiperspirant compositions that incorporate ethylene diamine disuccinate salts as replacements for ethylenediaminetraacetic acid salts.

Abstract: Provided are: a method for producing a mycrosporine-like amino acid (MAA) that includes a step in which microbes are cultivated that produce MAA on the outside of bacterial cells, a step in which the bacterial cells and extracellular culture fluid are separated, and a step in which the MAA is recovered from the extracellular culture fluid; an MAA indicated by formula (1), an MAA produced using this method, or an ultraviolet-absorbing composition including the MAA indicated by formula (1); and a composition including the MAA produced using this method or the MAA indicated by formula (1), for preventing at least one symptom or disease selected from a group comprising acute skin reactions, aging of the skin, and skin cancer.

Abstract: Coloring agents for keratin fibers, in particular for human hair, include—based on their weight—at least one compound selected from the group of oxidation dye precursors, substantive dyes and mixtures thereof, 0.1 to 5% by weight dicarboxylic acid(s) having 2 to 10 carbon atoms and/or salt(s) of said acid(s), 20 to 95% by weight water and less than 0.1% by weight peroxide compound(s), result in oxidative coloring agents with improved fiber protection.

Abstract: A shampoo composition having from about 0.025% to about 0.25% histidine, by weight of the shampoo composition; from about 2% to about 50% of one or more detersive surfactants, by weight of the shampoo composition; and a gel matrix having from about 0.1% to about 20% of one or more fatty alcohols, by weight of the gel matrix; from about 0.1% to about 10% of one or more gel matrix surfactants, by weight of the gel matrix; and from about 20% to about 95% of an aqueous carrier, by weight of the gel matrix.

Abstract: A method of inhibiting copper deposition on hair and facilitating the removal of copper deposited on hair including applying to the hair a shampoo composition having histidine, rinsing the shampoo composition from the hair, applying to the hair a conditioner composition comprising histidine, and rinsing the conditioner composition from the hair.

Abstract: Use of spiculisporic acid and/or a salt thereof as antidandruff agent, and cosmetic treatment process employing same. The present invention relates to the cosmetic use, especially for hair, of spiculisporic acid and/or a salt thereof as anti dandruff agent. The invention also relates to a cosmetic treatment process intended for eliminating dandruff and/or for reducing the amount thereof, comprising the application, to the hair and/or the scalp, of spiculisporic acid and/or a salt thereof, or of a cosmetic composition comprising it/them.

Abstract: A color-stable topical gel containing dihydroxyacetone, erythrulose, and vanillin in a sunless tanning, self-tanning, anti-aging, anti-oxidant formulation that gives the skin a longer lasting tan, without the use of dyes, stains or colorants.

Abstract: The present invention generally relates to compositions and methods for topical or transdermal delivery, treatment of skin, and improving the appearance of skin, e.g., medically or cosmetically. In some cases, the composition may include nitric oxide and/or peptides such as thyrotropin-releasing hormone (TRH) and/or GnRH (gonadotropin-releasing hormone). The nitric oxide and/or peptide may be present within a first phase comprising a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present in liposomes, micelles, or other structures containing nitric oxide, peptides, or both. The composition can take the form of a gel, a cream, a lotion, an ointment, a solution, a solid “stick,” etc., that can be rubbed or sprayed onto the skin. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like.

Abstract: The present invention provides a topical composition for application to a keratinous tissue comprising a cosmetically or pharmaceutically acceptable carrier; one or more selected from potassium, zinc, calcium, rubidium disposed in the cosmetically or pharmaceutically acceptable carrier; and one or more peptides disposed in the cosmetically or pharmaceutically acceptable carrier.

Abstract: The invention relates to compositions comprising polyglycerol esters and hydroxyalkyl-modified guar.

Abstract: The present disclosure relates to methods of retarding hair loss or facilitating hair growth and/or regrowth. More specifically, the present disclosure relates to methods of using the disclosed compositions to increase the rate of terminal hair growth and/or regrowth in a mammal.

Abstract: The present disclosure relates to an effect of promoting hyaluronic acid synthesis of a pomegranate concentrate. A pomegranate concentrate, prepared by treating pomegranate with a starch-degrading enzyme and passing the same through a heating concentration process and having an ellagic acid content of 0.8 mg/g or higher and a polyphenol content of 8 mg/g or higher, has an effect of promoting hyaluronic acid. According to the present disclosure, hyaluronic acid synthesis can be promoted and skin moisturization can be improved by administering a food or pharmaceutical composition containing the pomegranate concentrate as an active ingredient to a subject in need of promotion of hyaluronic acid synthesis.

Abstract: The invention relates to a Truffle extract for skin cosmetic use, comprising compounds having a molecular weight of less than 5 kDa. The invention also relates to a cosmetic method of treatment designed to reduce and/or correct the signs of aging and photo-aging of the skin and keratinous appendages, and to protect the skin against aggressions due to ultraviolet radiation.

Abstract: Provided are a liposome composition in which an osmotic pressure of an inner water phase is 2-fold to 8-fold relative to the osmotic pressure of an outer water phase, and which encapsulates a water-soluble drug in a dissolved state, and also exhibits excellent preservation stability; and a method for producing the same. According to the present invention, it is possible to provide a liposome composition, including liposomes obtained from lipids dissolved and emulsified in an organic solvent, each of which has an inner water phase and an aqueous solution which constitutes an outer water phase and in which the liposomes are dispersed, in which each of the liposomes encapsulates a water-soluble drug in a dissolved state, and an osmotic pressure of the inner water phase is 2-fold to 8-fold relative to the osmotic pressure of the outer water phase; and a method for producing the same.

Abstract: A preparation method of lipid bubbles by utilizing the principle of natural adsorption and assembly of amphiphilic lipid molecules on a gas-liquid interface comprises the steps of mixing gas-dissolved water containing free bubbles with lipid materials, and then the lipid materials are dispersed in the free gas nanobubble aqueous solution, and, in the presence of free bubbles, adsorbed and assembled on the gas-liquid interfaces so as to form lipid bubbles. The method is different from the traditional ultrasound cavitation, the mechanical force action, the novel ink jet printing method, the microchannel method and other methods for preparing bubbles.

Abstract: The present invention provides liposome compositions containing sparingly soluble drugs that are used to treat life-threatening diseases. A preferred method of encapsulating a drug inside a liposome is by remote or active loading. Remote loading of a drug into liposomes containing a transmembrane electrochemical gradient is initiated by co-mixing a liposome suspension with a solution of drug, whereby the neutral form of the compound freely enters the liposome and becomes electrostatically charged thereby preventing the reverse transfer out of the liposome. There is a continuous build-up of compound within the liposome interior until the electrochemical gradient is dissipated or all the drug is encapsulated in the liposome. However, this process as described in the literature has been limited to drugs that are freely soluble in aqueous solution or solubilized as a water-soluble complex. This invention describes compositions and methods for remote loading drugs with low water solubility (<2 mg/mL).